Dana-Faber Cancer Institute — Boston, Massachusetts

Dana-Faber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Faber Cancer Institute has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumor, Adult, Castration Resistant Metastatic Prostate Cancer, Metastatic Breast Cancer.

Sponsors: Corbus Pharmaceuticals Inc., Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Janssen Diagnostics, LLC.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Faber Cancer Institute?

Dana-Faber Cancer Institute has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Faber Cancer Institute conducted?

Dana-Faber Cancer Institute has 3 clinical trials on record, with 2 currently active. Their work covers Solid Tumor, Adult, Castration Resistant Metastatic Prostate Cancer, Metastatic Breast Cancer.

Is Dana-Faber Cancer Institute accredited by Crixeo Health?

Dana-Faber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Faber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.